ArticleProceedings of the National Academy of Sciences of the United States of America2025

Fine structural design of 3βHSD1 inhibitors for prostate cancer therapy.

Dongyin He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.